The American Journal of Managed Care19h
Shaping Gene Therapy Approaches in Neuromuscular Disease
Adeno-associated virus (AAV)–mediated gene therapy was one of the focal points of this year's Muscular Dystrophy Association conference. Here, Barry Byrne, MD, PhD, University of Florida, speaks to ...
Bionova Scientific's $100 million project in The Woodlands close to starting, filing says
After scoring tax abatements for a $100 million investment in The Woodlands last year, the company appears to be close to beginning the project.
The Financial Express17h
End of medicine as we know it
The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around drug resistant ...
Sarepta says teen died after its gene therapy treatment
Sarepta Therapeutics said on Tuesday a young man has died due to acute liver failure after treatment with its gene therapy for a rare muscular dystrophy.
The American Journal of Managed Care20h
Data Gaps Leave Long-Term Impact of Ex Vivo Gene Therapy in DMD Uncertain
Giulio Cossu, MD, speaks to the lingering safety concerns related to ex vivo gene therapy in Duchenne muscular dystrophy (DMD) as long-term data are yet to be established.
News-Medical.Net on MSN23h
In the Thymus We Trust: ProTcell Therapy & the Future of Allogeneic Immunotherapy
In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.
Scientists gain insight into RNA-editing protein that could lead to improved treatment for cancer, autoimmune diseases
A research team has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ribonucleic acid (RNA) induced immune responses. Their findings could open new pathways for ...